BIOMAT Database Logo BIOMAT Database Logo

[Design, synthesis and biological evaluation of novel 4-substituted-3-nitrobenzamide derivatives]. 2014

Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao

A series of novel 4-substituted-3-nitrobenzamide derivatives were designed and synthesized. The structures of the target compounds were confirmed with 1H NMR, 13C NMR, MS and element analysis. Anti-tumor activities against HCT-116, MDA-MB435 and HL-60 cell lines in vitro were evaluated by SRB assay. The results indicated most of the target compounds exhibited potent anti-tumor activity. Compound 4a showed the most potent inhibitory activities against three cancer cell lines with the GI50 values of 1.904-2.111 micromol x L(-1). Compounds 4g, 41-4n exhibited more potent inhibitory activities against MDA-MB435 and HL-60 cell lines with the GI50 values of 1.008-3.586 micromol x L(-1) and 1.993-3.778 micromol x L(-1), respectively. The structure-activity relationship of these compounds is discussed preliminarily.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001549 Benzamides BENZOIC ACID amides.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D018922 HL-60 Cells A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8) HL60 Cells,Cell, HL60,Cells, HL60,HL 60 Cells,HL-60 Cell,HL60 Cell
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
February 2017, Bioorganic & medicinal chemistry letters,
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
September 2018, Molecules (Basel, Switzerland),
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Synthesis and biological evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
August 2013, Organic & biomolecular chemistry,
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
August 2016, Bioorganic & medicinal chemistry letters,
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents.
July 2017, European journal of medicinal chemistry,
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Synthesis and biological evaluation of N-antipyrine-4-substituted amino-3-chloromaleimide derivatives.
November 2010, European journal of medicinal chemistry,
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
October 2017, European journal of medicinal chemistry,
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Design, Synthesis, Docking and Biological Evaluation of Novel 4-hydroxy Coumarin Derivatives.
January 2021, Current computer-aided drug design,
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Design, synthesis and biological evaluation of novel 4-hydroxybenzene acrylic acid derivatives.
March 2011, Bioorganic & medicinal chemistry letters,
Qi-Feng Zhu, and Yong-Xiang Gong, and Jin-Qing Zhong, and Li-Fei Liu, and Xu-Fei Li, and Xu-Yang Zhao
Design, synthesis and biological evaluation of 3-(4-halophenyl)-3-oxopropanal and their derivatives as novel antibacterial agents.
September 2010, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!